Edition:
United States

Heska Corp (HSKA.OQ)

HSKA.OQ on NASDAQ Stock Exchange Capital Market

42.52USD
4:00pm EDT
Change (% chg)

$-0.33 (-0.77%)
Prev Close
$42.85
Open
$43.16
Day's High
$43.37
Day's Low
$42.50
Volume
9,671
Avg. Vol
23,994
52-wk High
$44.97
52-wk Low
$26.27

HSKA.OQ

Chart for HSKA.OQ

About

Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital... (more)

Overall

Beta: 0.62
Market Cap(Mil.): $286.33
Shares Outstanding(Mil.): 6.68
Dividend: --
Yield (%): --

Financials

  HSKA.OQ Industry Sector
P/E (TTM): 51.44 42.79 36.62
EPS (TTM): 0.83 -- --
ROI: 8.90 11.52 14.52
ROE: 9.73 13.50 15.68

BRIEF-Heska Q1 earnings per share $0.17

* Q1 earnings per share view $-0.02 -- Thomson Reuters I/B/E/S

May 03 2016

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $36.67 -0.18
Novartis AG (NOVN.S) CHF80.30 -1.60
Merck & Co., Inc. (MRK.N) $58.43 -0.17
Bayer AG (BAYGn.DE) €94.31 -0.31
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €76.29 -0.41
Eli Lilly and Co (LLY.N) $82.93 -0.47
IDEXX Laboratories, Inc. (IDXX.OQ) $93.21 +0.44
Virbac SA (VIRB.PA) €176.80 -0.65
Vetoquinol SA (VETO.PA) €39.00 +0.38

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : New Constructs, LLC
$25.00
Provider : Wright Reports
$75.00
Provider : ValuEngine, Inc.
$25.00
Provider : Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.